COVID-19 Resources Archives | Frier Levitt

Lessons Learned from the First Wave of COVID-19: How to Navigate the Second Wave and Implement Lasting Changes to Benefit your Practice

Guillermo J. Beades, Esq., Wiks Moffat, CHC and Jim Tudor, PCA, CPC February 1, 2021

by Guillermo Beades, Esq. of Frier Levitt, LLC, Wiks Moffat, CHC, of HealthCare Compliance Network, LLC, and Jim Tudor, PCA, CPC, of HealthCare Compliance Network, LLC When the COVID-19 pandemic reached our shores, it instantly changed the way we... Read More

NJ Employers Weigh Vaccine Rules Against Legal Liability

Jesse C. Dresser, Esq. January 29, 2021

Frier Levitt Life Sciences Partner Jesse Dresser, Esq., who heads the Firm's Pharmacy Practice Group, recently spoke to Law360 about "NJ Employers Weigh Vaccine Rules Against Legal Liability." Jesse says that "he's seeing more educational... Read More

Blogs & Articles | COVID-19 Resources | Employment Matters | Life Sciences

Pharmacy ALERT: CVS Caremark Nearly Doubles Drugs on “Aberrant Quantities” Product List Effective January 2021

Dae Y. Lee, Esq., Pharm.D CPBS and Harini Bupathi, Esq. January 7, 2021

In 2019, Frier Levitt reported a new dispensing limitation CVS Caremark (“Caremark”) introduced in its retail networks that took effect on January 1, 2020. Specifically, Caremark issued an “Aberrant Product List” that identified... Read More

Blogs & Articles | Community, Retail Pharmacies | COVID-19 Resources | Life Sciences

Employment Law Alert: Families First Coronavirus Response Act (FFCRA) set to expire on December 31, 2020; no renewal in sight

Sean E. Sanders, Esq. and Michelle L. Greenberg, Esq. December 21, 2020

Despite the continuing increase in COVID-19 cases and the limit on gatherings, the Families First Coronavirus Response Act (FFCRA) will expire on December 31, 2020. Enacted in March 2020, the FFCRA provided extra expanded leave entitlements to... Read More

Blogs & Articles | COVID-19 Resources | Employment Matters | Healthcare

Recent HHS Announcement Further Expands Access to Telehealth, But Does CMS’ Final Rule Do the Same?

Jonian Rafti, Esq. and Arielle T. Miliambro, Esq. December 4, 2020

HHS Permits Out-of-State Telehealth Providers to Render Certain Services Nationwide On December 3, 2020, the Department of Health and Human Services (“HHS”) announced a fourth amendment to its declaration under the Public Readiness and... Read More

Blogs & Articles | COVID-19 Resources | Healthcare | Telehealth and Telemedicine

PHARMACY ALERT: PBM Audits in the Time of COVID-19

Dae Y. Lee, Esq., Pharm.D CPBS and Harini Bupathi, Esq. November 23, 2020

The continuing COVID-19 pandemic has caused most business operations to go virtual, and PBMs have followed this trend. Earlier this year, we reported that PBMs had briefly suspended audits of pharmacies in an alleged effort to ensure pharmacies were... Read More

Blogs & Articles | Community, Retail Pharmacies | COVID-19 Resources | Defending Pharmacies in PBM Audits | Life Sciences

Insurers Begin to Roll Back Telehealth Fee Waivers

Jonian Rafti, Esq. and Arielle T. Miliambro, Esq. October 7, 2020

As Frier Levitt has mentioned in previous articles, insurers have nearly unanimously waived cost-sharing requirements for virtual telehealth visits since the onset of the Coronavirus pandemic. Recently, however, certain payors have begun to roll... Read More

Blogs & Articles | COVID-19 Resources | Healthcare | Telehealth and Telemedicine

UPDATE: PBMs Have Slowly Begun to Lift Certain Flexibilities Implemented During COVID-19 While Extending Other Relaxations in Policies and Procedures

Payal Amin, Pharm.D., RPh, Esq. and Jesse C. Dresser, Esq. September 25, 2020

As a result of the COVID-19 pandemic, many Pharmacy Benefit Managers (“PBMs”) had taken some form of action to help prioritize patient care including providing safe access to prescription drugs. Many of the flexibilities and changes in policy... Read More

Blogs & Articles | COVID-19 Resources | Defending Pharmacies in PBM Audits | Life Sciences

What Happens If a Loved One Passed From COVID-19 Related Care?

Jonathan Levitt, Michelle L. Greenberg, Esq. and Christopher Caltavuturo, Esq. September 4, 2020

Over 185,000 Americans and counting have lost their lives battling COVID-19. Health care providers have fought hard for patients and the Government has granted them, along with vaccine manufacturers, broad immunity from liability. However, victims... Read More

COVID-19 Resources

U.S. Patent and Trademark Office Expedited Patent and Trademark Review

Martha M. Rumore Pharm.D., Esq. August 12, 2020

The U.S. Patent and Trademark Office (USPTO) recently announced the COVID-19 Trademark Prioritized Examination Program as well as a Prioritized Examination Pilot Program for Patent Applications. For trademarks, the program allows COVID-19-related... Read More

Blogs & Articles | COVID-19 Resources | Healthcare Law | Pharmacy Law

Category: COVID-19 Resources